Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votesGovInfo API
Floor speeches, reports, bill textFederal Election Commission (FEC)
Campaign financeVoteView (UCLA)
Ideology scores (DW-NOMINATE)GovTrack.us
Misconduct data (CC0)U.S. Census Bureau
District demographics

Data Last Updated

Bills & Votes: Less than 1 hour agoSenate Race Ratings: 2 hours agoHouse Race Ratings: 2 hours ago
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

HR9421Referred to Committee

To prohibit a REMS-certified provider from prescribing mifepristone without an in-person visit and a medical license in the State in which the patient resides, and for other purposes.

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-06-24
Introduced
3
Cosponsors
HR
ⓘ
Type

Sponsor

Sheri Biggs
Sheri Biggs
Republican · SC · Representative
Votes with party: 91.6% (592 recorded votes)

Full profile: /officials/B001325

Source: Congress.gov · FEC

Cosponsors (3)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

  • Ralph Norman (R-SC-5)Original· 2026-06-24
  • Russell Fry (R-SC-7)Original· 2026-06-24
  • Harriet M. Hageman (R-WY)· 2026-07-06

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Energy and Commerce.

2026-06-24

Source: Congress.gov

Committee Activity

Currently in

  • House Committee on Energy and CommerceReferred To · 2026-06-24

Plain-English Summary

This bill would require doctors to meet with patients in person before prescribing mifepristone (a medication used for abortion) and would limit prescriptions to doctors licensed in the state where the patient lives. The changes would restrict the current ability to prescribe this medication through telehealth or mail, affecting patients seeking medication abortion and the healthcare providers who serve them. The bill is currently under review by a House committee.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.

  • HR9592To authorize the Secretary of State to take certain actions to counter and reduce threats to the space security of the United States, to require the Secretary of State to provide certain consultations to Congress on the space security of the United States, and for other purposes.
    Referred to Committee · 2026-07-06
  • HR9328Improving Travel for Military Members Act
    Reported by Committee · 2026-06-24
  • HR8213Defending Women in the Workplace Act
    Referred to Committee · 2026-04-09
  • HR8040No Mercy for Terrorists Act of 2026
    Referred to Committee · 2026-03-24